{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:07:23Z","timestamp":1760782043881},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2000,10]]},"DOI":"10.1067\/mjd.2000.107499","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T04:17:08Z","timestamp":1027570628000},"page":"631-634","source":"Crossref","is-referenced-by-count":17,"title":["Raynaud's phenomenon, anticentromere antibodies, and digital necrosis without sclerodactyly: An entity independent of scleroderma?"],"prefix":"10.1067","volume":"43","author":[{"given":"Evelyn M.","family":"Sachsenberg-Studer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christa","family":"Prins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Hilaire","family":"Saurat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2000.107499_bib1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2230.1994.tb01199.x","article-title":"Anticentromere antibodies ACA: clinical distribution and disease specificity","volume":"19","author":"Chan","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1067\/mjd.2000.107499_bib2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/art.1780340111","article-title":"Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease","volume":"34","author":"Weiner","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1067\/mjd.2000.107499_bib3","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/ard.47.8.634","article-title":"Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting","volume":"47","author":"Kallenberg","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"10.1067\/mjd.2000.107499_bib4","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/art.1780350614","article-title":"Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis","volume":"35","author":"Wigley","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1067\/mjd.2000.107499_bib5","first-page":"875","article-title":"Systemic sclerosis and digital gangrene without scleroderma","volume":"15","author":"Barr","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1067\/mjd.2000.107499_bib6","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/rheumatology\/36.8.889","article-title":"Six cases positive for anti-centromere antibodies with ulcer and gangrene in the extremities","volume":"36","author":"Takahashi","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1067\/mjd.2000.107499_bib7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00005792-198011000-00001","article-title":"Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon","volume":"59","author":"Rodnan","year":"1982","journal-title":"Medicine"},{"key":"10.1067\/mjd.2000.107499_bib8","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/ard.53.8.540","article-title":"Anticardiolipin, anti-centromere and anti-Scl-70 antibodies in patients with systemic sclerosis and severe digital ischemia","volume":"53","author":"Herrick","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1067\/mjd.2000.107499_bib9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1067\/mjd.2000.107499_bib10","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1067\/mjd.2000.107499_bib11","first-page":"942","article-title":"Vasculitis in systemic sclerosis: association with Sj?gren's syndrome and the CREST syndrome variant","volume":"14","author":"Oddis","year":"1987","journal-title":"J Rheumatol"},{"key":"10.1067\/mjd.2000.107499_bib12","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/bmj.292.6527.1037","article-title":"Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon","volume":"292","author":"Reilly","year":"1986","journal-title":"Br Med J"},{"key":"10.1067\/mjd.2000.107499_bib13","first-page":"99","article-title":"Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon","volume":"12","author":"Seibold","year":"1985","journal-title":"J Rheumatol"},{"key":"10.1067\/mjd.2000.107499_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/art.1780300306","article-title":"Nicardipine in the treatment of Raynaud's phenomenon: dissociation of platelet activation from vasospasm","volume":"30","author":"Wigley","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1067\/mjd.2000.107499_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0889-857X(21)01040-1","article-title":"Vascular disease in scleroderma: endothelial T lymphocyte-fibroblast interactions","volume":"16","author":"Kaheleh","year":"1990","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1067\/mjd.2000.107499_bib16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/art.1780330218","article-title":"Prolonged improvement of Raynaud's phenomenon and scleroderma after recombinant tissue plasminogen activator therapy","volume":"33","author":"Fritzler","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1067\/mjd.2000.107499_bib17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/bmj.2.6136.523","article-title":"Treatment of Raynaud's phenomenon by fibrinolytic enhancement","volume":"2","author":"Jarrett","year":"1978","journal-title":"Br Med J"},{"key":"10.1067\/mjd.2000.107499_bib18","first-page":"137","article-title":"Efficacy evaluation of prostaglandin E1 against placebo in patients with progressive systemic sclerosis and significant Raynaud's phenomenon","volume":"47","author":"Bartolone","year":"1999","journal-title":"Minerva Cardioangiol"},{"key":"10.1067\/mjd.2000.107499_bib19","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/rheumatology\/37.9.952","article-title":"Oral iloprost in Raynaud's phenomenon secondary to systemic sclerosis: a multicentre, placebo-controlled, dose-comparison study","volume":"37","author":"Black","year":"1998","journal-title":"Br J Rheumatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096220021579X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096220021579X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T14:51:00Z","timestamp":1680533460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096220021579X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["S019096220021579X"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2000.107499","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2000,10]]}}}